Search For "covax"
AIIMS Delhi to start Covaxin trials on children in few days, say sources
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): After All India Institute of Medical Sciences (AIIMS), Patna, now AIIMS Delhi is also planning to start the Paediatric clinical trials of the indigenous Bharat Biotech's COVID-19 vaccine "Covaxin" in few days, sources said on Thursday.
Read More
Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in
Updated : 4 years, 9 months ago IST
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Read More
Bihar: Covaxin trials on children begin at Patna's AIIMS
Updated : 4 years, 9 months ago IST
Patna (Bihar) [India], June 3 (ANI): Patna's All India Institute of Medical Sciences (AIIMS) has started the paediatric trials for the COVID-19 vaccine manufactured by the Bharat Biotech, Covaxin.
Read More
Japan's PM Yoshihide Suga pledges additional USD 800 million to COVAX faci
Updated : 4 years, 9 months ago IST
Tokyo [Japan], June 3 (ANI): Japanese Prime Minister Yoshihide Suga on Wednesday pledged an additional USD 800 million to COVAX facility aiming for a fair distribution of coronavirus vaccines worldwide.
Read More
SC directs Centre to submit complete data on purchase history of COVID-19
Updated : 4 years, 9 months ago IST
New Delhi [India], June 2 (ANI): The Supreme Court on Wednesday directed the Central government to submit complete data on its purchase history along with administration of doses of all the COVID-19 vaccines-- Covaxin, Covishield and Sputnik V-- till date.
Read More
Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 2 (ANI): Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a Maharashtra government undertaking, is preparing for mass production of Covaxin and will have capacity to produce over 22 crore doses of the COVID-19 vaccine every year once the requisit
Read More
Mixing of COVID-19 vaccines not protocol yet, clarifies Centre
Updated : 4 years, 9 months ago IST
New Delhi [India], June 1 (ANI): The Government of India on Tuesday clarified that mixing of COVID-19 vaccines is not protocol yet and asserted there is no change in the schedule of two-dose vaccines Covishield and Covaxin.
Read More
Delhi left with 3,190 vaccine doses for 18-44 age group
Updated : 4 years, 10 months ago IST
New Delhi [India], May 31 (ANI): Delhi is left with 3,190 COVID vaccine doses in its balance stock out of which 1,120 doses are of Covaxin and 2,070 of Covishield reserved for the age group 18-44 years, informed the Delhi government.
Read More
Bharat Biotech to ramp up production of Covaxin to 10-12 crore doses by Ju
Updated : 4 years, 10 months ago IST
New Delhi [India], May 31 (ANI): With ramping up of production capacities, nearly 25 crore ‘Made in India’ vaccine doses are expected to be available by August, a senior official has said and noted that it will go a long way in meeting the target of vaccinating one crore peopl
Read More
Regulatory body in Pakistan rushes to register Pfizer vaccine after shipme
Updated : 4 years, 10 months ago IST
Islamabad [Pakistan], May 30 (ANI): The Drug Regulatory Authority of Pakistan (Drap) is rushing to register the Pfizer COVID-19 vaccine, after a shipment with 100,000 doses of the vaccine arrived in the country, under the COVAX initiative, without any clearance.
Read More
Delhi receives fresh COVID-19 vaccine stock from Centre for 45+
Updated : 4 years, 10 months ago IST
New Delhi [India], May 29 (ANI): Delhi received a fresh stock of COVID-19 vaccine that includes 48,890 doses of Covaxin and 83,970 doses of Covishield from the Centre, said Aam Aadmi Party (AAP) MLA Atishi on Saturday.
Read More
Covaxin production takes 120 days depending on technology framework, regul
Updated : 4 years, 10 months ago IST
New Delhi [India], May 28 (ANI): Amid reports of shortage of its COVID-19 vaccine in the country, Bharat Biotech on Friday said that the timeline for manufacturing, testing, and release for a batch of Covaxin is approximately 120 days, depending on the technology framework and regulatory
Read More